Neil Bhowmick
Chief Scientific Officer, Kairos Pharma, LTD.
Companies
- Kairos Pharma, LTD.Chief Scientific Officer Sep 24, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Kairos Pharma, LTD. KAPA1,311,739 shares2$880.2K at $0.67Oct 8, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Oct 8, 2025Granted 171,756 shares of Kairos Pharma, LTD.2
- Jan 1, 2025Granted 14,000 shares of Kairos Pharma, LTD.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Apr 7, 2025